Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Lon E Bell is Director at Exozymes. OQRO lists 1 transaction filed with the SEC under this name, the latest on Oct 19, 2026, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
ExozymesEXOZ
Oct 1, 202610Kdisclosed Oct 19
DetailsOfficial recordLon E Bell bought shares on the open market in 8 different years since 2007, and has not bought since 2020 across 3 companies. Sales in 1 of the 20 years since 2007.
Lon E Bell reported 25 open-market purchases and 27 sales since 2007; purchases in 8 different years, most recently 2020.
| Year | Bought | Sold |
|---|---|---|
| 2020 | $27K11×11 trades | — |
| 2019 | $501K1×1 trade | — |
| 2018 | $250K1×1 trade | — |
| 2017 | $234K7×7 trades | — |
| 2016 | $105K2×2 trades | — |
| 2015 | $500K1×1 trade | — |
| 2013 | $100K1×1 trade | — |
| 2012 | $200K1×1 trade | — |
| 2007 | — | $2.85M27×27 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Lon E Bell bought shares on the open market in 8 different years since 2007, and has not bought since 2020 across 3 companies. Sales in 1 of the 20 years since 2007.
In SEC filings since 2007: the latest open-market purchase is from 2020; the latest open-market sale is from 2007.
3 companies: Ideal Power (IPWR, 2013–2020), Clearsign Technologies (CLIR, 2012–2018), Gentherm Incorporated (THRM, 2007).
Lon E Bell reported 0 open-market purchases and 27 sales here, 2007.
Lon E Bell reported 22 open-market purchases and 0 sales here, 2013 to 2020.
Lon E Bell reported 3 open-market purchases and 0 sales here, 2012 to 2018.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.